SS Innovations International SSII
NASDAQ SSII
$3.59 -0.02 (-0.69%)
At close: Aug 21, 2026 · 4:00 PM EDT

SS Innovations International (SSII) Cash from Financing Activities (2016 - 2026)

SS Innovations International (SSII) posted Cash from Financing Activities of $18.2 million for Q1 2026, up 1222.47% sequentially from $1.4 million in Q4 2025, and down 18.95% YoY from $22.4 million in Q1 2025.

SS Innovations International (SSII) Cash from Financing Activities (2016 - 2026) Analysis & Trends

SS Innovations International has reported Cash from Financing Activities for 11 years, with the latest figure at $18.2 million in Q1 2026.

  • Quarterly Cash from Financing Activities fell 18.95% year-over-year to $18.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.9 million (down 24.91% YoY) and the FY2025 annual result came in at $26.2 million, up 177.6% from the prior year.
  • Cash from Financing Activities climbed to $18.2 million in Q1 2026 per SSII's latest filing, from $1.4 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $22.4 million in Q1 2025 and troughed at -$702098.0 in Q2 2025.
  • A 5-year average of $5.4 million and a median of $2.7 million in 2024 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2022 and 2025: Cash from Financing Activities jumped 15516.71% in 2022, then sank 126.45% in 2025.
  • Over 5 years, Cash from Financing Activities stood at $3.1 million in 2022, then slumped by 95.1% to $150563.0 in 2023, then soared by 2165.52% to $3.4 million in 2024, then slumped by 59.74% to $1.4 million in 2025, then soared by 1222.47% to $18.2 million in 2026.
  • According to Business Quant data, Cash from Financing Activities over the past three periods registered $18.2 million, $1.4 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -3.52 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -95.00 Mn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -410.00 Mn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -300,000.00
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -607.30 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -236.00 Mn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn -1.34 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -213.50 Mn
10 SS Innovations International 714.49 Mn 692.19 Mn 7.10 Mn 3.48 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.48 Mn
Jun 30, 2026 3.48 Mn
Mar 31, 2026 18.16 Mn
Mar 31, 2026 18.16 Mn
Dec 31, 2025 1.37 Mn
Dec 31, 2025 1.37 Mn
Sep 30, 2025 3.09 Mn
Sep 30, 2025 3.09 Mn
Jun 30, 2025 -702,098.00
Jun 30, 2025 -702,098.00
Mar 31, 2025 22.41 Mn
Mar 31, 2025 22.41 Mn
Dec 31, 2024 3.41 Mn
Dec 31, 2024 3.41 Mn
Sep 30, 2024 722,336.00
Sep 30, 2024 722,336.00
Jun 30, 2024 2.65 Mn
Jun 30, 2024 2.65 Mn
Mar 31, 2024 2.64 Mn
Mar 31, 2024 2.64 Mn